A seasoned leader in the pharmaceutical and diagnostics industry, specialized in structuring international healthcare sales joins the team to accelerate international expansion SeqOne Genomics,
The Homologous Recombination Deficiency (HRD) biomarker identifies ovarian cancer patients likely to respond to PARP-inhibitors. SeqOne's test simplifies the deployment of this test while
The funding will drive international deployment of the company’s next generation genomic analysis platform to enable personalized medicine in cancers as well as rare and hereditary diseases. .
La Bourgogne-Franche-Comté bien présente au Sirha de Lyon macommune.info - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from macommune.info Daily Mail and Mail on Sunday newspapers.